33261-117 NDC - OMEPRAZOLE ()

Drug Information

Product NDC: 33261-117

Proprietary Name: Omeprazole

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Aidarex Pharmaceuticals LLC
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:1/21/2009

Package Information

No. Package Code Package Description Billing Unit
133261-117-02120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33261-117-02)
233261-117-066 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33261-117-06)EA
333261-117-1010 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33261-117-10)
433261-117-2020 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33261-117-20)
533261-117-3030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33261-117-30)EA
633261-117-6060 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33261-117-60)EA
733261-117-9090 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33261-117-90)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC33261-117An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
PROPRIETARY NAMEOmeprazole 
START MARKETING DATE1/21/2009 
LABELER NAMEAidarex Pharmaceuticals LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023